Ozempic
-
Trump says prices for Ozempic, other weight-loss drugs to drop in U.S.Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.U.S. NewsNov 6
-
Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuringOzempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.WorldSep 10
-
-
Advertisement
-
Ozempic approved in Canada to reduce kidney decline in people with diabetesThe patients taking the drug were also less likely to die from cardiovascular disease — another condition that affects many patients with diabetes.HealthAug 19
-
-
Advertisement
-
University of Manitoba studies Ozempic marketingResearchers at the University of Manitoba are looking at how marketing for drugs like Ozempic and Wegovy influence peoples' views on food, hunger, and weight.HealthJul 23
-
Ozempic, Wegovy linked to rare cases of eye disorder, EMA saysCalled non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.ConsumerJun 6
-
-
Drugs like Ozempic may lower cancer risk if you have diabetes: studyExcess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.HealthMay 23
-
-
Ozempic microdosing: Weight-loss hack or just a placebo?As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. But experts have concerns.HealthMay 6
-
Ozempic for youth? Childhood obesity care gets an overhaul in CanadaThe new approach recommends focusing on quality of life and mental health — and even includes medications like GLP-1s, which include Ozempic for kids 12 and up when needed.HealthApr 14
-
-
Advertisement
-
Drugs like Ozempic could ‘significantly’ cut Alzheimer’s risk, study findsNew research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.HealthApr 7
-
-
Advertisement
-
Canadian scientist awarded for discovering hormone used in OzempicDr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.CanadaApr 7
Trending
-
Edmonton father dies in hospital E.R. waiting to see a doctor105,627 Read -
Canada backs Greenland’s sovereignty as U.S. talks of annexation14,708 Read -
Boxing Day Canada: Your ultimate guide to must-shop early deals14,466 Read -
Lawsuit by Humboldt Broncos’ families dismissed by judge13,079 Read -
Carney says ‘we’ve got to keep on this track’ as he looks ahead to 20269,845 Read -
Donald Trump says ‘pathetic trainwreck’ Stephen Colbert should be taken off air6,625 Read -
Top Videos
-
Edmonton father dies waiting to see a doctor in hospital E.R.130 Viewed -
Family of Highway 1 crash victim speaks25 Viewed -
The Calgary communities seeing effects of citywide rezoning the most and least22 Viewed -
Global News Hour at 6 Edmonton: Dec. 2421 Viewed -
Edmonton father dies waiting to see a doctor in hospital E.R. -